These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 2514661

  • 1. [Protective effect of cicletanine in hypertensive retinopathy. Evaluation of retinal function in the isolated retina].
    Millerin M, Doly M, Betin C, Malherbe E, Droy MT, Braquet P.
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():175-9. PubMed ID: 2514661
    [Abstract] [Full Text] [Related]

  • 2. [Malignant hypertensive retinopathy in spontaneously hypertensive stroke-prone rats. Effect of treatment with cicletanine].
    Ruchoux MM, Droy-Lefaix MT, Bakri F, Berthet P, Bosquet D, Lhuintre Y.
    Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1281-4. PubMed ID: 2510662
    [Abstract] [Full Text] [Related]

  • 3. Cicletanine and hypertensive retinopathy.
    Ruchoux MM, Droy-Lefaix MT, Bakri F, Guillemain J, Ruchoux P, Autret A.
    Ophthalmic Res; 1990 Jul; 22(5):318-29. PubMed ID: 2090985
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Effectiveness of cicletanine on lesions in spontaneously hypertensive rats. Curative study--dose-effect relationship].
    Droy-Lefaix MT, Ruchoux MM, Berthet P, Bakri F, Bosquet D, Narcisse G, Guillemain G.
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():163-8. PubMed ID: 2514659
    [Abstract] [Full Text] [Related]

  • 6. [Effects of treatment with cicletanine on kidney PGE2 and PGI1 in spontaneously hypertensive rats].
    Deby C, Deby-Dupont G, Droy-Lefaix MT, Bosquet D, Berthet P, Bakri F.
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():37-40. PubMed ID: 2514666
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of cicletanine on cerebrovascular injury in stroke-prone spontaneously hypertensive rats.
    Ruchoux MM, Huguet F, Droy-Lefaix MT, Gelot A, Ruchoux P, Autret A.
    Am J Hypertens; 1989 Sep; 2(9):683-9. PubMed ID: 2803675
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vivo and in vitro effects of cicletanine in spontaneously hypertensive rats.
    Auguet M, Guillon JM, Delaflotte S, Le Hegarat M, Pirotzky E, Clostre F, Braquet P.
    Drugs Exp Clin Res; 1988 Sep; 14(2-3):89-95. PubMed ID: 3416727
    [Abstract] [Full Text] [Related]

  • 11. [Involvement of PAF (Platelet-Activating Factor) in chloroquine-induced retinopathy].
    Meyniel G, Doly M, Millerin M, Braquet P.
    C R Acad Sci III; 1992 Sep; 314(2):61-5. PubMed ID: 1559183
    [Abstract] [Full Text] [Related]

  • 12. Pattern electroretinography in a rat model of ocular hypertension: functional evidence for early detection of inner retinal damage.
    Ben-Shlomo G, Bakalash S, Lambrou GN, Latour E, Dawson WW, Schwartz M, Ofri R.
    Exp Eye Res; 2005 Sep; 81(3):340-9. PubMed ID: 16129101
    [Abstract] [Full Text] [Related]

  • 13. [Tilorone-induced functional changes in the rat retina].
    Bredehorn T, Duncker GI.
    Klin Monbl Augenheilkd; 2000 Apr; 216(4):219-22. PubMed ID: 10820707
    [Abstract] [Full Text] [Related]

  • 14. Characterization of retinal injury using ERG measures obtained with both conventional and multifocal methods in chronic ocular hypertensive primates.
    Hare WA, Ton H, Ruiz G, Feldmann B, Wijono M, WoldeMussie E.
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):127-36. PubMed ID: 11133857
    [Abstract] [Full Text] [Related]

  • 15. Vascular actions of cicletanine.
    Bukoski RD, Wagman DW, de Wan P, Xue H.
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():45-50. PubMed ID: 2514668
    [Abstract] [Full Text] [Related]

  • 16. Quantification of ischemic damage in the rat retina: a comparative study using evoked potentials, electroretinography, and histology.
    Jehle T, Wingert K, Dimitriu C, Meschede W, Lasseck J, Bach M, Lagrèze WA.
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1056-64. PubMed ID: 18326730
    [Abstract] [Full Text] [Related]

  • 17. Review of three studies to determine the efficacy and tolerance of cicletanine in the short- and long-term treatment of essential hypertension.
    Fodor GP, Guinot P.
    Drugs Exp Clin Res; 1988 Mar; 14(2-3):195-204. PubMed ID: 3046883
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of cicletanine with other antihypertensive drugs in SHR-SP models.
    Malherbe E, Le Hegarat M, Clostre F, Braquet P.
    Drugs Exp Clin Res; 1988 Mar; 14(2-3):83-8. PubMed ID: 2970955
    [Abstract] [Full Text] [Related]

  • 20. Retinal dysfunction in diabetic ren-2 rats is ameliorated by treatment with valsartan but not atenolol.
    Phipps JA, Wilkinson-Berka JL, Fletcher EL.
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):927-34. PubMed ID: 17251496
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.